[1]
2022. Molecular Profiling and Prognostic Value of KRAS Gene Mutations in Tumor Samples and Liquid Biopsies from Patients with Pancreatic Ductal Adenocarcinoma. Annals of Gastroenterology and Digestive Disorders. 5, 1 (Sep. 2022), 1–15.